In conclusion, the use of probiotics by patients with advanced CKD was associatedwith decreases in the levels of syndecan-1 and blood glucose, indicating a potentialimprovement in metabolism and decreased systemic inflammation. This evidence concerns the gene SDC1 and chronic kidney disease.